![](https://endpts.com/wp-content/uploads/2024/05/Robert-Blum-Cytokinetics-via-Twitter-X-tile1.jpg)
Robert Blum, Cytokinetics CEO (Cytokinetics via X)
Cytokinetics CEO defends Royalty Pharma deal: 'That narrative was hijacked'
Cytokinetics CEO Robert Blum blamed investor frustration over a deal with Royalty Pharma on a “hijacked” narrative that the company would be better off selling …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.